Study in Argentina shows safety of combining Sputnik V with other vaccines
BUENOS AIRES, July 31. /TASS/: A study conducted in Argentina did not reveal any serious side effects when combining the first component of the Russian coronavirus vaccine Sputnik V with drugs from AstraZeneca and Sinopharm, the government of province of Buenos Aires announced on Friday.
"The Ministry of Health of the province of Buenos Aires reports that, according to preliminary results, during the ongoing safety study of combining the Sputnik V vaccine with the drugs AstraZeneca and Sinopharm, no serious side effects have been identified," the government announced.